AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Feb 19, 2014
30016_dirs_2014-02-19_b8569c23-d826-44e2-9eee-db2ddd43afbf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-02-14
Reporting Person: Fiarman Jeffrey (EVP, GEN COUNSEL & SECRETARY)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-14 | Non-Qualified Stock Option (right to buy) | $124.00 | A | 6407 | Acquired | 2024-02-13 | Common Stock (6407) | Direct |
| 2014-02-14 | Incentive Stock Option (right to buy) | $124.00 | A | 806 | Acquired | 2024-02-13 | Common Stock (806) | Direct |
| 2014-02-14 | Restricted Stock Unit | $ | A | 706 | Acquired | Common Stock (706) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock becomes exercisable as to 1,443 shares on 02/14/2015, 02/14/2016, 02/14/2017, 1,442 shares on 02/14/2018, and the remaining 636 shares on 02/14/2019.
F2: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2019) of the grant.
F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.